The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide ...

Steam may be more powerful than you think. It smooths clothes and kills germs, but now doctors are testing it against cancer. At Keck Medicine of USC, part of a large nationwide study, researchers are ...

September is Prostate Cancer Awareness Month, and when many men choose to get check-ups. Though the month is nearly over, UAMS is reminding Arkansans that vigilance in getting prostate cancer ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate cancer. The international study, published in The New England Journal of ...

A new at-home saliva test for prostate cancer could outperform current testing methods, a new study suggests. Researchers have developed a simple spit test, that can be performed at home and does not ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

The Nuclear Medicine Department at Ridley-Tree Cancer Center (now part of Sutter Health) has announced greater capabilities to treat prostate cancer using the injectable radioligand therapy, Pluvicto ...

Prostate cancer is something that nobody wants to have. Thankfully, with modern medical advancements, there are different ways to fight and treat the disease. Dr. Gregg Franklin with the New Mexico ...

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...

Former President Joe Biden announced this weekend that he has been diagnosed with an aggressive form of prostate cancer, the second leading cause of cancer death for men in the United States. About 1 ...